NCT01636726 WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction Status COMPLETED Phase N/A
NCT01635361 Understanding and Appraising the New Medicine Service in England Status COMPLETED Phase NA
NCT01635088 Onset and Duration of Mometasone by Oscillometry and Spirometry Status COMPLETED Phase PHASE4
NCT01634152 Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma Status COMPLETED Phase PHASE3
NCT01634139 Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma Status COMPLETED Phase PHASE3
NCT01634113 Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma Status COMPLETED Phase PHASE2
NCT01631760 Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation Status WITHDRAWN Phase N/A
NCT01631162 The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples Status UNKNOWN Phase NA
NCT01629849 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects Status COMPLETED Phase PHASE1
NCT01629823 Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP) Status COMPLETED Phase NA
NCT01627158 Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte Status COMPLETED Phase PHASE1
NCT01624974 Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011) Status COMPLETED Phase PHASE2
NCT01621386 Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513) Status COMPLETED Phase PHASE1
NCT01620099 Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study Status COMPLETED Phase PHASE4